TEL/AML 1 real-time quantitative reverse transcriptase PCR can complement minimal residual disease assessment in childhood ALL

Leukemia. 2005 Jul;19(7):1296-7. doi: 10.1038/sj.leu.2403759.
No abstract available

Publication types

  • Comparative Study
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Child
  • Core Binding Factor Alpha 2 Subunit
  • Humans
  • Immunoglobulins / genetics
  • Neoplasm, Residual / diagnosis*
  • Oncogene Proteins, Fusion / genetics*
  • Precursor Cell Lymphoblastic Leukemia-Lymphoma / diagnosis*
  • Prospective Studies
  • Receptors, Antigen, T-Cell / genetics
  • Reverse Transcriptase Polymerase Chain Reaction / methods*

Substances

  • Core Binding Factor Alpha 2 Subunit
  • Immunoglobulins
  • Oncogene Proteins, Fusion
  • Receptors, Antigen, T-Cell
  • TEL-AML1 fusion protein